Susan Eylward's most recent trade in Imunon Inc was a trade of 417 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Imunon Inc | Susan Eylward | General Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2025 | 417 | 417 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Susan Eylward | General Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 6,250 | 6,250 | - | - | Stock Option (Right to Buy) | |
| Imunon Inc | Susan Eylward | General Counsel and Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Oct 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) |